OPTISCAN IMAGING (OIL) - Pioneering Precision Surgery: CEO Camile Farah on the Game-Changing InVue Device and Transformative Partnership with the Mayo Clinic

ASX BRIEFS

Send us a text

Unlock the future of precision surgery with Camile Farah, the trailblazing CEO of Optiscan Imaging. In our latest ASX Briefs episode, Camile uncovers the revolutionary InVue device, a game-changer in cancer treatment. Imagine surgeons being able to see individual cancer cells in real-time—this isn't science fiction, it's happening now, and it's dramatically improving surgical outcomes. Camile shares how this cutting-edge technology reduces the need for second-stage surgeries, alleviates patient anxiety, and transforms the entire surgical workflow.
We also delve into Optiscan's strategic moves in the surgical market and their exciting partnership with the Mayo Clinic to advance robotic surgery technology. Camile's insights reveal how high-resolution, sub-micron level imaging is setting new standards in medical technology, empowering surgeons to make more informed decisions on the spot. Whether you're a healthcare professional, a tech enthusiast, or someone intrigued by medical innovations, this episode is packed with invaluable information on how Optiscan is leading the charge in precision surgery.